Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Completed · Phase 4 · Has a placebo group

Conditions studied: Coronary Artery Bypass Graft Surgery, Atherosclerosis, Vein Occlusion

In brief

The purpose of this study is to determine if evolocumab added to regular statin therapy improves vein graft patency after coronary artery bypass graft (CABG) surgery.

Key facts

Study ID
NCT03900026
Run by
Unity Health Toronto
People needed
782
Starts
2019-05-30
Expected to finish
2025-01-30
Last updated by the study team
2025-08-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.